Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 45,989,301
Avg Vol 115,232,406
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 15%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Adaptimmune Therapeutics plc engages in research, development, and subsequent manufacture and commercialisation of cell therapies to treat cancer in the United States and the United Kingdom. The company was founded in 2008 and is headquartered in Abingdon, the United Kingdom.

Industry: Biotechnology
Sector: Healthcare
Address:
The Innovation Centre, 99 Park Drive, Milton Park, Abingdon, United Kingdom
Ttubular
Ttubular Jul. 15 at 11:34 AM
$ADAPY just wish this would so we can move on
0 · Reply
US_Bull
US_Bull Jul. 15 at 11:30 AM
$ADAPY Just to be clear obviouslylike everyone else I wan tthe highest SH value we all wan tthat but I am also realistic and M&A scene has changed over the past years with companies protecting their money with inflation and other geopolitical issues. Private equity I believe would still make us exit with a nice profit that is the name of the game make profit and move on. Bulls make money, bears make money, pigs get slaughtered.
0 · Reply
US_Bull
US_Bull Jul. 15 at 11:21 AM
$ADAPY These are my likely scenarios do your own DD you will likely have different opinion and that is cool that is what the messaging board is for. As the DD expands scenarios change that is how investing is: i) GHO Private Equity (My guess chance ~ 35-40%) ii) Midsize BO (Most likely guesses could be either Immunocore, Immatics, or Iovance ~ 20-25%) iii) BP BO (Most likely guess could be Astrazeneca ~ 10-15%) iv) USW merger ~10-15% (I believe it would have happened by now and befor ethe service agreement ended company would have to be 'non-dark' state) v) Zombie company taken over by Tang or similar (5-10%) vi) Partnership they have tried it before and gave it up (5-10%)
0 · Reply
US_Bull
US_Bull Jul. 15 at 11:01 AM
$ADAPY Yup exactly as per below BP is at it already!
0 · Reply
US_Bull
US_Bull Jul. 15 at 10:52 AM
0 · Reply
US_Bull
US_Bull Jul. 15 at 10:52 AM
0 · Reply
US_Bull
US_Bull Jul. 15 at 10:52 AM
$ADAPY Our patents even disclose explicitly that it can target immune related ailments.
0 · Reply
US_Bull
US_Bull Jul. 15 at 10:51 AM
0 · Reply
US_Bull
US_Bull Jul. 15 at 10:50 AM
0 · Reply
US_Bull
US_Bull Jul. 15 at 10:45 AM
$ADAPY So if company does indeed get BO and not the desperate private equity route, it could be a cross bridge between a cancer anti-inflammation BP.
0 · Reply
Latest News on ADAPY
No data available.
Ttubular
Ttubular Jul. 15 at 11:34 AM
$ADAPY just wish this would so we can move on
0 · Reply
US_Bull
US_Bull Jul. 15 at 11:30 AM
$ADAPY Just to be clear obviouslylike everyone else I wan tthe highest SH value we all wan tthat but I am also realistic and M&A scene has changed over the past years with companies protecting their money with inflation and other geopolitical issues. Private equity I believe would still make us exit with a nice profit that is the name of the game make profit and move on. Bulls make money, bears make money, pigs get slaughtered.
0 · Reply
US_Bull
US_Bull Jul. 15 at 11:21 AM
$ADAPY These are my likely scenarios do your own DD you will likely have different opinion and that is cool that is what the messaging board is for. As the DD expands scenarios change that is how investing is: i) GHO Private Equity (My guess chance ~ 35-40%) ii) Midsize BO (Most likely guesses could be either Immunocore, Immatics, or Iovance ~ 20-25%) iii) BP BO (Most likely guess could be Astrazeneca ~ 10-15%) iv) USW merger ~10-15% (I believe it would have happened by now and befor ethe service agreement ended company would have to be 'non-dark' state) v) Zombie company taken over by Tang or similar (5-10%) vi) Partnership they have tried it before and gave it up (5-10%)
0 · Reply
US_Bull
US_Bull Jul. 15 at 11:01 AM
$ADAPY Yup exactly as per below BP is at it already!
0 · Reply
US_Bull
US_Bull Jul. 15 at 10:52 AM
0 · Reply
US_Bull
US_Bull Jul. 15 at 10:52 AM
0 · Reply
US_Bull
US_Bull Jul. 15 at 10:52 AM
$ADAPY Our patents even disclose explicitly that it can target immune related ailments.
0 · Reply
US_Bull
US_Bull Jul. 15 at 10:51 AM
0 · Reply
US_Bull
US_Bull Jul. 15 at 10:50 AM
0 · Reply
US_Bull
US_Bull Jul. 15 at 10:45 AM
$ADAPY So if company does indeed get BO and not the desperate private equity route, it could be a cross bridge between a cancer anti-inflammation BP.
0 · Reply
US_Bull
US_Bull Jul. 15 at 10:44 AM
$ADAPY The future of cell therapy is gonna be curing inflammatory conditions and not just cancer that is where the real money is. I have previously posted that PRAME is believed to be heavily involved in maintaining a healthy immune system blocking an overactive immune system. Don't disregard the fact that whoever bought our PRAME asset may not necessarily be a cancer company. Still a big mystery why they wouldn't tell us the company. If it was USW they definitely would have told us, which makes me believe it is a BP.
0 · Reply
US_Bull
US_Bull Jul. 15 at 10:40 AM
$ADAPY @duepillagence Galapagos has turned into Lakefront Biotherapeutics their oncology program is completely gone. https://lakefrontbio.com/innovation/pipeline/
1 · Reply
Stonky_Mcprofitface
Stonky_Mcprofitface Jul. 14 at 10:16 PM
$ADAPY One of the shoe shine boys outside the Nantucket homeless shelter I live at in the summer says he heard that the company will do a pivot to AI or crypto. Think Leap Therapeutics or Allbirds. The NOLs alone are worth dozens of dollars.
1 · Reply
mjtx86
mjtx86 Jul. 14 at 9:30 PM
$ADAPY I hope this is the beginning of the next leg up
0 · Reply
TradeX_
TradeX_ Jul. 14 at 7:51 PM
Looks like BMGL might be the next 800% runner. Crazy market! Every micro float ticker has been going parabolic this month. Would not be surprised if they send BMGL up now. BMGL starting to make its move now! Only 750k shares outstanding! 💎 been watching $BETR $ADAPY $GNPX $QS as well
0 · Reply
PaidPiper
PaidPiper Jul. 14 at 7:02 PM
$ADAPY wow spoken like a true self-diluted A hole
1 · Reply
US_Bull
US_Bull Jul. 14 at 6:33 PM
$ADAPY Nonesense hardly the stock doesn't just magically climb up with no cause but good luck chasing the charts lol. I gave you proof and reasons why it made the move up pretty obvious you are just a short term trader and know nothing about the company buddy. Again reason why it climbed up to 4 cents was because of ASCO Tecelra data (doubt you even know the data since you just popped up a week ago lol) and the move from the expert market to otc. Assuming you were correct stock would have been surging today on monster vol. and it is not. Hence it is waiting for the next leg up but that will only come with the next corporate update. Good luck to you.....
0 · Reply
duepillagence
duepillagence Jul. 14 at 6:30 PM
$ADAPY This is called a "carve out".. It originated with the Galapagos agreement and survived transfer to the Us Worldmeds purchase agreement.. It is alive and active. "But, but Adaptimmune has no infrastructure to develop, manufacture or commercialize?" Hence why they will seek a merger..
0 · Reply
Stonky_Mcprofitface
Stonky_Mcprofitface Jul. 14 at 5:59 PM
$ADAPY But according to his promise we are waiting for new heavens and a new earth in which righteousness dwells.
0 · Reply
Stonky_Mcprofitface
Stonky_Mcprofitface Jul. 14 at 5:39 PM
$ADAPY Check LinkedIn. The truth is out there for those who seek it.
1 · Reply
ricoti
ricoti Jul. 14 at 5:15 PM
$ADAPY 1.4 million Ask wall came down . Let's see if we fly, or another magical wall.
0 · Reply
Ricofly123
Ricofly123 Jul. 14 at 4:16 PM
$ADAPY Patience
0 · Reply